CAMLINFINE NSE filing

Camlin Fine Sciences Announces 33rd AGM on Aug 11, 2026, Releases FY26 Annual Report

The RealCase readLow impact Neutral

Camlin Fine Sciences will hold its 33rd AGM on August 11, 2026. The company has released its Annual Report for FY 2025-26. Shareholders are urged to update KYC details for physical securities to ensure timely payments.

Why it matters

This is a standard regulatory announcement regarding the AGM and the release of the annual report, with no immediate material impact on the company's operations or stock price.

The market read

The announcement is a routine corporate communication regarding the AGM and availability of the annual report, with no significant positive or negative financial or operational news.

Camlin Fine Sciences Limited has announced its 33rd Annual General Meeting (AGM) scheduled for Tuesday, August 11, 2026, at 10:00 AM IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM).

In compliance with SEBI Listing Regulations, electronic copies of the AGM notice and the Annual Report for the Financial Year 2025-26 are being sent to shareholders who have registered their email addresses. For members whose email addresses are not registered, the company is sending a letter providing a web link to access the Annual Report 2025-26. The Annual Report is also available on the company's website at https://www.camlinfs.com/annual-report-2025-2026/.

The company also reminded shareholders holding physical securities about the SEBI mandate to update KYC details, including PAN, address, mobile number, bank account details, specimen signature, and nomination choice. This update is crucial for receiving payments like dividends, interest, or redemption, especially with electronic mode becoming mandatory from April 1, 2024, for updated folios. Shareholders are encouraged to register their email addresses to receive all important information and documents electronically and to support the Green Initiative.

Filing to action

What to do with a filing like this

Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.

View original filing